460 related articles for article (PubMed ID: 19803404)
21. Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update.
Jellinger KA; Lantos PL
Acta Neuropathol; 2010 Jun; 119(6):657-67. PubMed ID: 20309568
[TBL] [Abstract][Full Text] [Related]
22. The role of alpha-synuclein in the pathogenesis of multiple system atrophy.
Wenning GK; Jellinger KA
Acta Neuropathol; 2005 Feb; 109(2):129-40. PubMed ID: 15666181
[TBL] [Abstract][Full Text] [Related]
23. An autopsy case of early ("minimal change") olivopontocerebellar atrophy (multiple system atrophy-cerebellar).
Wakabayashi K; Mori F; Nishie M; Oyama Y; Kurihara A; Yoshimoto M; Kuroda N
Acta Neuropathol; 2005 Aug; 110(2):185-90. PubMed ID: 15971057
[TBL] [Abstract][Full Text] [Related]
24. [Study on argyrophilic inclusions of multisystem atrophy (Oppenheimer)].
Iwabuchi K; Kosaka K; Haga C; Tuchiya K; Amano N; Itoh K; Yagishita S; Mizutani Y
No To Shinkei; 1991 Jun; 43(6):561-8. PubMed ID: 1654964
[TBL] [Abstract][Full Text] [Related]
25. Tau-positive glial cytoplasmic granules in multiple system atrophy.
Nagaishi M; Yokoo H; Nakazato Y
Neuropathology; 2011 Jun; 31(3):299-305. PubMed ID: 21062361
[TBL] [Abstract][Full Text] [Related]
26. Progressive accumulation of ubiquitin and disappearance of alpha-synuclein epitope in multiple system atrophy-associated glial cytoplasmic inclusions: triple fluorescence study combined with Gallyas-Braak method.
Sakamoto M; Uchihara T; Nakamura A; Mizutani T; Mizusawa H
Acta Neuropathol; 2005 Oct; 110(4):417-25. PubMed ID: 16133540
[TBL] [Abstract][Full Text] [Related]
27. Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes.
Armstrong RA; Cairns NJ; Lantos PL
Parkinsonism Relat Disord; 2006 Sep; 12(6):356-62. PubMed ID: 16723266
[TBL] [Abstract][Full Text] [Related]
28. Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson's disease.
Mochizuki A; Komatsuzaki Y; Shoji S
Acta Neuropathol; 2002 Nov; 104(5):534-7. PubMed ID: 12410401
[TBL] [Abstract][Full Text] [Related]
29. [Multiple system atrophy (MSA)].
Riku S
Rinsho Shinkeigaku; 1995 Dec; 35(12):1448-51. PubMed ID: 8752426
[TBL] [Abstract][Full Text] [Related]
30. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
Sone M; Yoshida M; Hashizume Y; Hishikawa N; Sobue G
Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
[TBL] [Abstract][Full Text] [Related]
31. [MSA update].
Tsuji S
Rinsho Shinkeigaku; 2005 Nov; 45(11):821-3. PubMed ID: 16447735
[TBL] [Abstract][Full Text] [Related]
32. Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy.
Komori T; Ishizawa K; Arai N; Hirose T; Mizutani T; Oda M
Acta Neuropathol; 2003 Jul; 106(1):66-70. PubMed ID: 12669242
[TBL] [Abstract][Full Text] [Related]
33. Alpha-synuclein binding to rab3a in multiple system atrophy.
Dalfó E; Ferrer I
Neurosci Lett; 2005 May 20-27; 380(1-2):170-5. PubMed ID: 15854772
[TBL] [Abstract][Full Text] [Related]
34. Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: A quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system).
Ishizawa K; Komori T; Arai N; Mizutani T; Hirose T
Neuropathology; 2008 Jun; 28(3):249-57. PubMed ID: 18312549
[TBL] [Abstract][Full Text] [Related]
35. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration.
Yazawa I; Giasson BI; Sasaki R; Zhang B; Joyce S; Uryu K; Trojanowski JQ; Lee VM
Neuron; 2005 Mar; 45(6):847-59. PubMed ID: 15797547
[TBL] [Abstract][Full Text] [Related]
36. Distribution and dynamic process of neuronal cytoplasmic inclusion (NCI) in MSA: correlation of the density of NCI and the degree of involvement of the pontine nuclei.
Yokoyama T; Kusunoki JI; Hasegawa K; Sakai H; Yagishita S
Neuropathology; 2001 Sep; 21(3):145-54. PubMed ID: 11666010
[TBL] [Abstract][Full Text] [Related]
37. XIAP immunoreactivity in glial and neuronal cytoplasmic inclusions in multiple system atrophy.
Kawamoto Y; Ito H; Ihara M; Takahashi R
Clin Neuropathol; 2014; 33(1):76-83. PubMed ID: 23993308
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy.
Koga S; Dickson DW
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):175-184. PubMed ID: 28860330
[TBL] [Abstract][Full Text] [Related]
39. Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration.
Piao YS; Hayashi S; Hasegawa M; Wakabayashi K; Yamada M; Yoshimoto M; Ishikawa A; Iwatsubo T; Takahashi H
Acta Neuropathol; 2001 Mar; 101(3):285-93. PubMed ID: 11307630
[TBL] [Abstract][Full Text] [Related]
40. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy.
Arima K; Uéda K; Sunohara N; Arakawa K; Hirai S; Nakamura M; Tonozuka-Uehara H; Kawai M
Acta Neuropathol; 1998 Nov; 96(5):439-44. PubMed ID: 9829806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
